SEC Form 4 · accession 0001209191-17-067417
Cue Biopharma, Inc. · CUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin Sandercock
Officer — SVP, General Counsel and Sec
Period of report
Dec 27, 2017
Accepted (ET)
Dec 27, 2017 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645460
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $7.50 | Dec 27, 2017 | A | 150,000 | A | — | Dec 27, 2024 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1These Stock Options become exercisable in eight equal semi-annual installments beginning June 5, 2018.